Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Treu Jesse I
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   24    
Direct Shares   55,258    

Indirect Shares

   2,983,502      
Direct Value   $37,649    

Indirect Value

   $10,776,798      
Total Shares   3,038,760      
Total Value   $10,814,447      


Northstar Neuroscience Inc $0 Volcano Corp $0 Orexigen Therapeutics, Inc. $80 Veracyte, Inc. $37,569 Northstar Neuroscience Inc $0 Volcano Corp $0 Orexigen Therapeutics, Inc. $80 Veracyte, Inc. $37,569
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Nuvasive Inc NUVA 10% Owner 0 2004-05-18 31,204    Premium*  
            Senomyx Inc SNMX 10% Owner 0 2004-06-25 19,603    Premium*  
            Santarus Inc SNTS 10% Owner 2004-04-06 0 2004-04-06 64,471    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX Director 2010-06-09 0 2009-12-18 0    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 2006-04-18 0 2006-12-12 21,068    Premium*  
            Northstar Neuroscience Inc NSTR Director 2007-05-18 17,231 2007-05-18 14,690    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 2006-05-15 0 2009-01-30 67,875    Premium*  
            Volcano Corp VOLC 10% Owner 2008-04-24 21,289 2008-07-16 62,513    Premium*  
            Cadence Pharmaceuticals Inc CADX 10% Owner 0 2014-03-19 0    Premium*  
            Orexigen Therapeutics, Inc. OREX 10% Owner 2007-11-27 15,096 2011-12-22 50,643    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2010-04-27 0 2011-06-02 40,790    Premium*  
            Achillion Pharmaceuticals Inc ACHN 10% Owner 0 2013-01-18 244,057    Premium*  
            Zogenix, Inc. ZGNX 10% Owner 2010-11-29 0 2011-09-16 169,251    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2011-11-21 0 2011-11-21 51,013    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 0 2012-07-24 22,306    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 0 2013-07-01 35,253    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2013-07-15 0 2013-07-15 1,920,730    Premium*  
            Tobira Therapeutics Inc TBRA Director, 10% Owner 0 2013-08-27 32,091    Premium*  
            Evoke Pharma Inc EVOK 10% Owner 0 2013-09-30 24,256    Premium*  
            Veracyte, Inc. VCYT Director 2019-03-04 1,642 2019-03-04 1,641    Premium*  
            Tandem Diabetes Care Inc TNDM Director, 10% Owner 2013-11-19 0 2013-11-19 54,390    Premium*  
            Dicerna Pharmaceuticals Inc DRNA 10% Owner 2014-02-04 0 2014-02-04 13,004    Premium*  
            Achaogen Inc AKAO 10% Owner 2014-03-17 0 2014-03-17 33,890    Premium*  
            Aldeyra Therapeutics, Inc. ALDX Director 2019-03-26 0 2019-03-26 8,763    Premium*  
* Premium Members only  

Records found :    157         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 6 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-12-17 4 B $7.55 $755,000 I/I 100,000 42,122 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-08-11 4 B $7.60 $792,680 I/I 104,300 20,887 1.5 -
SOMX Somaxon Pharmaceuticals, ... Director   –       •      –    2009-12-17 4 S $1.04 $848,944 I/I (816,292) 0 0 -
ALDX Aldeyra Therapeutics, Inc... Director   –       •      –    2019-03-26 4 S $10.01 $968,397 I/I (96,743) 8,763 0 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-11-23 4 B $6.93 $1,039,500 I/I 150,000 39,606 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2008-12-08 4 B $4.47 $1,110,397 I/I 248,411 4,173 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2008-12-09 4 B $4.93 $1,192,518 I/I 241,890 8,237 1.5 -
VCYT Veracyte, Inc. Director   –       •      –    2018-08-01 4 S $10.85 $1,302,000 I/I (120,000) 16,804 0 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-11-20 4 B $6.93 $1,732,500 I/I 250,000 37,090 1.5 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2006-05-15 4 B $6.50 $2,999,997 I/I 461,538 98,075 1.5 -
TBRA Tobira Therapeutics Inc Director   –       •       •   2013-08-27 4 B $4.00 $3,000,000 I/I 750,000 2,571,117 2.25 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-08-12 4 B $8.00 $3,200,000 I/I 400,000 27,595 1.5 -
ESPR Esperion Therapeutics, In... 10% Owner   –       –       •   2013-07-01 4 B $14.00 $3,999,996 I/I 285,714 35,253 1.5 -
VCYT Veracyte, Inc. Director   –       •      –    2018-07-31 4 S $10.82 $4,111,600 I/I (380,000) 17,692 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2010-04-27 4 B $11.00 $4,158,308 I/I 378,028 4,829,773 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-07-23 4 B $7.50 $4,875,000 I/I 650,000 19,138 1.5 -
NSTR Northstar Neuroscience In... Director   –       •      –    2007-05-15 4 S $13.20 $5,002,800 I/I (379,000) 0 0 -
VCYT Veracyte, Inc. Director   –       •      –    2019-03-01 4 S $20.45 $5,623,750 I/I (275,000) 12,193 0 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2007-05-01 4 B $12.00 $6,300,000 I/I 525,000 104,975 1.5 -
ZGNX Zogenix, Inc. 10% Owner   –       –       •   2011-09-16 4 B $2.00 $7,000,000 I/I 3,500,000 169,251 1.5 -
DRTX Durata Therapeutics, Inc. 10% Owner   –       –       •   2012-07-24 4 B $9.00 $7,058,817 I/I 784,313 22,306 1.5 -
VCYT Veracyte, Inc. Director   –       •      –    2019-02-28 4 S $20.44 $7,176,400 I/I (350,000) 14,216 0 -
OCRX Ocera Therapeutics Inc 10% Owner   –       –       •   2013-07-15 4/A B $6.03 $7,999,992 I/I 1,327,491 1,857,036 1.5 -
OCRX Ocera Therapeutics Inc 10% Owner   –       –       •   2013-07-15 4 B $6.03 $7,999,992 I/I 1,327,491 1,897,336 1.5 -
VCYT Veracyte, Inc. Director   –       •      –    2019-03-04 4 S $20.21 $8,632,722 I/I (427,151) 0 0 -
  157  Records found
  1   2   3   4   5   6  7      
  Page 6 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us